RadNet Inc. to acquire iCAD Inc. in a ~$100M deal aimed at advancing AI breast cancer screening technology.
USC Norris opens a Newport Beach radiation oncology and imaging center, the first in Orange County to offer innovative biology-guided radiation therapy (BgRT) for precise cancer treatment.
Keck Medicine of USC has announced that it will open a four-story, 100,000-square-foot, state-of-the-art medical office building located at 590 S. Fair Oaks Ave. in Pasadena this fall.
City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.
UCLA Health researchers say study findings uncover Huntington’s disease mechanisms and pave new ways to develop treatments.
City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top research center for diabetes and other life-threatening illnesses, is leading a phase 1/2 clinical trial investigating an osteoporosis medication as a way to improve beta cell health in people with early type 1 diabetes.
Culver City-based ImmunityBio, Inc., a leading immunotherapy company, has announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the company’s ANKTIVA and CAR-NK (PD-L1 t-haNK) for the reversal of Lymphopenia in patients receiving standard-of-care chemotherapy/radiotherapy and in multiply relapsed locally advanced or metastatic pancreatic cancer.
Children’s Hospital Los Angeles has opened its new Cardiac Imaging Suite, a 6,650-square-foot facility that will improve access, service and quality of care for cardiac patients featuring state-of-the-art technology that cannot be found at any other pediatric center in the United States.
CHLA leads the country in one- and three-year liver graft and patient survival for pediatric liver transplants – and is among the top hospitals in transplant volume Children’s Hospital Los Angeles has the best one- and three-year post-transplant patient and graft survival rates in the nation for pediatric liver transplants, according to newly released 2025 data from the Scientific Registry of Transplant Recipients (SRTR) and the Organ Procurement and Transplant Network (OPTN).
Among the many homes that burned in Los Angeles’ most devastating firestorm to date, the Pacific Palisades Fire, was that of Ronit Menashe, CEO and co-founder of WeNatal.
